The Department of Health and Human Services's NAICS 325412 (Pharmaceutical Preparation Manufacturing) market: incumbents, spending trend, set-asides and open solicitations — from FY2026 USAspending awards and live SAM.gov notices.
Contract data as of Oct 18, 2026 (USAspending) · recent coverage verified weekly
| Quarter | Awards | Obligated | Change |
|---|---|---|---|
| Q1 FY2026 | 23 | $268.9M | — |
| Q2 FY2026 | 12 | $31.8M | -88% |
| Q3 FY2026 | 25 | $938.8M | +2848% |
| Q4 FY2026 | 25 | $98.5M | -90% |
Federal fiscal quarters (Q1 = Oct–Dec). Awards are counted in the quarter they start; obligations are the award's obligated amount.
| # | Contractor | Obligated | Share |
|---|---|---|---|
| 1 | MERCK & CO., INC. | $361.3M | 27.0% |
| 2 | GLAXOSMITHKLINE, LLC | $262.5M | 19.6% |
| 3 | PFIZER INC | $192.6M | 14.4% |
| 4 | SANOFI S A | $163.0M | 12.2% |
| 5 | GOVERNMENT OF THE UNITED STATES | $76.8M | 5.7% |
Registrations are rolled up to their corporate parent (USAspending parent UEI), so a company with several SAM registrations ranks once.
| Set-aside type | Obligated | Share |
|---|---|---|
| Small business set-aside | $1.9M | 0.2% |
| 8(a) | $0 | 0.0% |
| SDVOSB | $0 | 0.0% |
| WOSB / EDWOSB | $0 | 0.0% |
| HUBZone | $0 | 0.0% |
| No set-aside (full & open) | $1.2B | 99.8% |
Share of obligations on awards whose set-aside type is recorded — 91% of this market's dollars. Most USAspending bulk-archive records leave the field blank, so blank awards are excluded rather than counted as full & open.
Links open the notice on SAM.gov.
Source: USAspending.gov contract awards (prime awards with a start date from Oct 1, 2025 through Sep 30, 2026), SAM.gov contract opportunities, and SBA size standards. Recompetes are contracts whose final end date — options included — falls in the next 12 months. Figures are recomputed when a new USAspending load lands. See our data sources.